Category: Cardiometabolic Disease
-
GAME-CHANGERS IN FOCUS، A Quiz on Landmark Trials of 2024
April 15, 2025Quiz of 2024 landmark Trials
-
-
-
-
-
Daily Cardiology 5th Umbrella: The Art of Antithrombotic Therapy In Daily Cardiovascular Practice
January 26, 20255th Umbrella: Antithrombotic Therapy
-
-
-
-
-
-
Introduction of Hypertension and Hyperlipidemia Academy for non-physician healthcare providers
December 18, 2024Intro of H&H Academy for non-physician healthcare providers
-
Hypertension and Hyperlipidemia Academy for non-physician healthcare providers
December 2, 2024H&H Academy for non-physician healthcare providers
-
-
A Physical Activity and Sitting Time Balance Index and All-Cause Mortality Risk
October 30, 2024Sitting Time Balance Index
-
-
-
31st ESC 2024 Congress Coverage: ESC 2024 Chronic Coronary Syndromes Guideline (3)
October 13, 202431st ESC 2024: ESC 2024 CCS Guideline (3)
-
30th ESC 2024 Congress Coverage: ESC 2024 Chronic Coronary Syndromes Guideline (2)
October 12, 202430th ESC 2024: ESC 2024 CCS Guideline (2)
-
29th ESC 2024 Congress Coverage: Noise and Air Pollution as Risk Factors for Hypertension
October 12, 202429th ESC 2024: Noise and Air Pollution as RF for HTN
-
28th ESC 2024 Congress Coverage: ESC 2024 Chronic Coronary Syndromes Guideline (1)
October 12, 202428th ESC 2024: ESC 2024 CCS Guideline (1)
-
25th ESC 2024 Congress Coverage: ESC 2024 Guideline for Management of Peripheral Arterial and Aortic Diseases
October 9, 202425th ESC 2024: ESC 2024 PAAD Guideline
-
-
-
-
-
17th ESC 2024 Congress Coverage: Sudden Cardiac Death
September 30, 2024Among Persons with Diabetes Aged 1–49 years
-
-
-
10th ESC 2024 Congress Coverage: EARTH-STEMI meta-analysis
September 18, 202410th ESC 2024: EARTH-STEMI meta-analysis
-
9th ESC 2024 Congress Coverage: BedMed and BedMed-Frail Trials
September 18, 20249th ESC 2024: BedMed and BedMed-Frail Trials
-
-
-
-
-
-
-
Daily Cardiology Symposium 1403: Nutrition and Exercise
July 17, 2024DCS 1403: Nutrition and Exercise
-
-
-
-
-
-
-
-
-
-
-
Save The Date: Hypertension and Hyperlipidemia Academy, No. 16
May 7, 2024Save The Date: 15th H&H Academy
-
ACC.24 Congress Coverage: Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl
April 27, 2024ACC.24: REDUCE-IT trial
-
ACC.24 Congress Coverage: An “Inclisiran First” Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular Disease
April 27, 2024ACC.24: VICTORION-INITIATE trial
-
-
ACC.24 Congress Coverage: Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
April 16, 2024ACC.24: Semaglutide in HFpEF and DM
-
Impact: Why Do GLP-1 Drugs Stop Working, and What to Do About It?
April 6, 2024Impact: GLP-1 agonists in the treatment of obesity
-
-
-
-
Diabeat, 9th session: is Metformin still the champion for T2D and heart disease? a debate: Pros by Dr. Hadaegh
January 6, 2024Diabeat 9th session, case based discussion
-
Diabeat, 9th session: is Metformin still the champion for T2D and heart disease? a debate: Cons by Dr. Ghanavati
January 6, 2024Diabeat 9th session, case based discussion
-
Diabeat: the 9th diabetes masterclass for cardiologists, case-based discussion
December 30, 2023Diabeat 9th session, case based discussion
-
-
-
-
AHA23 Congress Coverage: Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a): A Randomized Dose-Ascending Clinical Trial
November 20, 2023A23 Congress Coverage: Lepodisiran Dose-Ascending Trial
-
AHA23 Congress Coverage: Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure: DAPA-MI trial
November 18, 2023AHA23 Congress Coverage: Dapagliflozin in MI without DM or HF (DAPA MI)
-
AHA23 Congress Coverage: Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes: SELECT trial
November 18, 2023AHA23 Congress Coverage: Semaglutide in obesity and no DM (SELECT trial)
-
Case Discussion 106: Approach to the diagnosis and management of asymptomatic hyperuricemia
November 13, 2023Case Discussion 102: asymptomatic hyperuricemia
-
-
-
Impact: When Does a Calcium Score Equate to Secondary Prevention?
September 30, 2023Impact: New Evidence for Interpreting Calcium Score
-
-
ESC 2023 Congress Coverage: 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
September 17, 2023ESC 2023: New DM and CVD Guideline
-
-
-
-
The Lost Puzzle In Diabetes Treatment: CAD and PAD in Patients with Diabetes
August 21, 2023CAD and PAD in DM
-
-
-
-
Vision: Adults with fasting TG=150-500mg with ASCVD or DM
July 3, 2023Vision: Mild hypertriglyceridemia in moderate to high risk patients
-
-
-
Hypertension and Hyperlipidemia Academy: clinical tips for nurses and non-physician healthcare professionals
May 18, 2023H&H Academy: clinical tips for non-physicians
-
-
Young Cardiologist Award 1402 Introduction video by Dr. Aminian
May 18, 2023YCA 1402 introduction by Dr. Aminian
-
-
Young Cardiologist Award 1402 Introduction video by Dr. Shishehbor
May 13, 2023YCA 1402 introduction by Dr. Shishehbor
-
-
-
Save the Date: American College of Cardiology 2023 Congress Coverage
May 1, 2023Save the Date: ACC.23 congress coverage
-
-
Young Cardiologist Award 1402 Introduction video by A. Yahyavi, MD
April 29, 2023YCA 1402 introduction by Dr. Yahyavi
-
-
Vision: Adults with fasting TG=150-500mg without ACVD or DM
April 15, 2023Vision: Mild hypertriglyceridemia in low-risk patients
-
Daily Cardiology Symposium 1402 Save The Date poster Motion
April 10, 2023DCS 1402 Save The Date Poster Motion
-
-
-
-
-
Hypertension and Hyperlipidemia Academy: Smoothing the path to cardiovascular risk reduction
February 15, 2023H&H Academy: CVD risk reduction
-
-
Impact: Healthy Eating Patterns and Risk of Total and Cause-Specific Mortality
February 13, 2023Impact: Healthy Eating and mortality risk
-
-
Impact: Experts Express Caution Over Type 2 Diabetes-Tea Drinking Claim
November 14, 2022Impact: Tea consumption and DM risk
-
Save the date: Cardiorenal Metabolic Crossroads, 5th session
September 13, 2022Save the date: Cardiorenal Metabolic Crossroads, 5th session
-
-
Save the date: Case-based discussion in patients with diabetes
August 30, 2022Save the date: Case-based discussion in patients with diabetes
-
-
-
-
-
-
-
Save the date: European Society of Cardiology 2022 congress coverage
August 22, 2022Save the date: ESC 2022 congress coverage
-
Save the date: Hypertension and Hyperlipidemia Academy No. 10
August 18, 2022Save the date: H&H Academy No. 10
-
-
Hypertension and Hyperlipidemia Academy, 10: for non-physician healthcare profesionals
July 19, 2022H&H Academy 10, for non-physician healthcare professionals
-
-
-
-
-
Save the date: Hypertension and Hyperlipidemia Academy, No. 9
June 28, 2022Save the date: The 9th H&H Academy
-
Daily Cardiology Symposium 1401, Day 1 Panel 1: Pharmacotherapy in CAD
June 26, 2022DCS 1401: Pharmacotherapy in CAD
-
-
-
-
-
-
-
Daily Cardiology Symposium 1401 faculty and executive committee motion
May 14, 2022DCS 1401 faculty and executive committee motion
-
Save the date: Hypertension and Hyperlipidemia Academy, 8th
May 10, 2022Save the date: 8th H&H Academy
-
American College of Cardiology (ACC) congress 2022 landmark trials review
May 3, 2022ACC 2022 congress coverage
-
Daily Cardiology Symposium 1401 faculty and executive committee
April 18, 2022DCS 1401 faculty and executive committee
-
-
-
-
Familial hypercholesterolemia, a narrative review, part 2: diagnosis and screening
March 11, 2022FH 1: diagnosis and screening
-
-
-
-
-
Umbrella: Hypertension, Challenges in the diagnosis & management of HTN
March 8, 2022Umbrella: HTN, diagnosis and management of HTN
-
Save the date: Hypertension and Hyperlipidemia Academy 7
March 3, 2022Save the date: the 7th H&H Academy session
-
Save the date: Cardiometabolic grand round 6
March 2, 2022Save the date: the 6th cardiometabolic grand round
-
-
-
-
-
-
-
-
Hypertension and Hyperlipidemia Academy: for nurses and medical assistants
January 18, 2022H&H Academy: nurses and assistants
-
Familial hypercholesterolemia, a narrative review, part 1: definition and burden
January 14, 2022FH 1: Definition and burden
-
Hypertension and Hyperlipidemia Academy 5, a hybrid event
January 7, 20225th session of H&H Academy, online and onsite
-
Save the date: A glimpse of DCS 1400 and invitation to DCS 1401
January 7, 2022DCS 1400 review and what’s coming next
-
Umbrella Heart and Stroke: session 2, carotid stenosis and stroke
January 2, 2022Umbrella H&S: session 2, carotid stenosis
-
-
-
-
Cardiometabolic Grand round, Session 5
November 21, 2021The 5th session of Cardiometabolic grand round
-
Save the date: Hypertension and hyperlipidemia academy, session 4
November 16, 2021The 4th session of Hypertension and hyperlipidemia academy
-
Save the date: Umbrella: Heart and Stroke
November 14, 2021The second program of Umbrella series: Heart and Stroke
-
Save the date: Cardiometabolic grand round, 5th session
November 8, 2021The 5th session of Cardiometabolic grand round program
-
Primary prevention in dyslipidemia as the only cardiovascular risk factor
November 4, 2021Dyslipidemia in primary prevention of low-risk patients
-
Late-breaking Science in Cardiovascular disease prevention
November 2, 2021ESC 2021 cardiovascular prevention guideline lectures and discussion
-
Save the date: Cardiorenal Metabolic Crossroads: Case-based Panel Discussion, 4th Session
November 1, 2021The 4th session of Cardiorenal metabolic crossroads program
-
Management of dyslipidemia in diabetic patients
October 24, 2021DLP and T2DM: approach and management
-
DiaBeat: The Beating Heart of Diabetes (8th session)
October 19, 20218th Diabetes Masterclass for Cardiologists
-
Save the date: Late-breaking Science in Cardiovascular disease prevention
October 19, 2021ESC 2021 cardiovascular prevention guideline lectures and discussion
-
Save the date; Cardiorenal Metabolic Crossroads: case-based panel discussion
October 10, 2021The second session of Cardiorenal metabolic crossroads program
-
Save the date; DiaBeat: The Beating Heart of Diabetes
October 9, 20218th Diabetes Masterclass for Cardiologists
-
-
Cardiopoint 13: Management of stage 1 hypertension in adults with low cardiovascular risk
September 25, 2021Stage 1 HTN in low risk patients
-
Cardio-Watch Podcast: Episode 7, ESC 2021 special
September 20, 2021The seventh episode of Cardio-Watch: ESC 2021
-
-
-
-
The clinical landscape for Diabetes and Cardiovascular disease
August 24, 2021T2DM and cardiovascular diseases: The clinical landscape
-
-
Long-term event-free and overall survival with Dapagliflozin in HFrEF patients
August 21, 2021Impact of Dapagliflozin on the survival of HFrEF patients
-
DiaBeat: The Beating Heart of Diabetes (7th session), a scientific debate
August 14, 20217th Diabetes Masterclass for Cardiologists
-
From optimal medical therapy to revascularization in CCS
August 14, 2021Choosing the best therapeutic strategy in CCS
-
Save the date: The first Umbrella event: chronic coronary syndrome
August 8, 2021First Umbrella session: CCS
-
Finding the optimal thromboprophylaxis regimen in patients with COVID-19
August 4, 2021Preventing thromboembolic events in COVID-19
-
-
Save the date: Diabeat: 7th session, SGLT2 Inhibitors for Primary Prevention of CVD
August 1, 20217th diabeat masterclass for cardiologists: SGLT2i in CVD primary prevention
-
Save the date: Umbrella, Focused cardiology forums
July 27, 2021The first session of Umbrella series
-
Tailored Antithrombotic therapy for CCS patients
July 25, 2021Best individual antithrombotic strategy in CCS
-
-
-
Cardio-Watch Podcast: Episode 5, cardiometabolic disorders
July 12, 2021The fifth episode of Cardio-Watch: cardiometabolic disorders
-
Marking the antiplatelet therapy maze in ACS
July 12, 2021How to prevent atherosclerotic cardiovascular events
-
Cardio-Watch Podcast: Episode 4, Dyslipidemia
June 28, 2021The fourth episode of Cardio-Watch: Dyslipidemia
-
DiaBeat: The Beating Heart of Diabetes (6th session)
June 24, 20216th Diabetes Masterclass for Cardiologists
-
Cardiometabolic Grand Round: 4th session
June 24, 2021Guideline-directed cardiovascular evaluations before surgery
-
Cardiovascular complications of T2DM: the preventive role of SGLT2Is
June 20, 2021SGLT2Is and the prevention of cardiovascular complications in T2DM
-
DCS 1400: session 2, Diabetes for cardiologists
June 16, 2021The second panel of DCS 1400: diabetes for cardiologists
-
DCS 1400: session 1, HTN and DLP
June 16, 2021The first panel of DCS 1400: hypertension and dyslipidemia
-
-
-
Save the date; DiaBeat: The Beating Heart of Diabetes
June 8, 20216th Diabetes Masterclass for Cardiologists
-
Save the date: Cardiometabolic Grand Round 4th session
June 1, 2021The fourth session of Cardiometabolic grand round
-
How to reduce the atherosclerotic cardiovascular risk
May 18, 2021A case-based Review on HTN and DLP management
-
Updates on the management of Diabetes and cardiometabolic disease
May 18, 2021Actoverco Diabetes Lunch Webinar
-
Cardio-Watch Podcast: Episode one; COVID-19 and the heart
May 15, 2021The first episode of Cardio-Watch podcast
-
The evolution of antiplatelet therapy in CAD: a 45 year journey
May 10, 2021A brief history of anti-platelet therapy in CAD
-
-
Impact: the paradox of physical activity in cardiovascular disease
May 2, 2021The contemporary Copenhagen general population study
-
DiaBeat: The Beating Heart of Diabetes (5th session)
May 1, 20215th Diabetes Masterclass for Cardiologists
-
Save the date: Abidi Hypertension and Hyperlipidemia Academy
April 19, 2021Keeping up-to-date on HTN and DLP treatment
-
Self-measured blood pressure monitoring at home
April 17, 2021What to teach the patients about recording their blood pressure themselves
-
DiaBeat: The Beating Heart of Diabetes (4th session)
April 12, 20214th Diabetes Masterclass for Cardiologists
-
DiaBeat: The Beating Heart of Diabetes (3rd session)
April 12, 20213rd Diabetes Masterclass for Cardiologists
-
DiaBeat: The Beating Heart of Diabetes (2nd session)
April 11, 20212nd Diabetes Masterclass for Cardiologists
-
DiaBeat: The Beating Heart of Diabetes (1st session)
April 10, 20211st Diabetes Masterclass for Cardiologists
-
Daily Cardiology Symposium 1400. Concise, Precise, Practical
April 10, 2021Case-based review of common cardiovascular practice The digital experience
-
PCSK9 inhibitors place in patients with cardiometabolic diseases
March 16, 2021PCSK9 inhibitors from two perspectives of Endocrinologist & Cardiologist
-
Save the date: Daily Cardiology Symposium 1400
March 11, 2021Case-based review of common cardiovascular practice
-
-
Cardiometabolic Grand Round (3)
February 27, 2021A brief talk on DM medication challenges in patients with CVD
-
An introduction to daily cardiology academy symposium; a digital learning opportunity
February 26, 2021Invitation for attending the symposium by executive directors
-
Save the date; DiaBeat: The Beating Heart of Diabetes
February 23, 20214th Diabetes Masterclass for Cardiologists
-
CardioPoint (10): The growing burden of cardiovascular diseases
February 2, 2021Emphasizing the importance of CVD prevention and management
-
Save the date; DiaBeat: The Beating Heart of Diabetes
January 28, 20213rd Diabetes Masterclass for Cardiologists
-
Introduction: Evolution of DOACs and their place in Guidelines
January 21, 2021A brief report of Guidelines mentioned DOACs place in practice
-
Save the date: To DOAC or Not To DOAC
January 21, 2021Rapid review of oral Anticoagulation practice in different clinical scenarios
-
To DOAC or Not to DOAC
January 21, 2021Rapid review of oral anticoagulation practice in different clinical scenarios
-
-
Save the date: 1st Daily Cardiology Symposium
January 19, 2021Case-based review of common cardiometabolic practice
-
Complete Session;SGLT2 inhibition: Making waves in the heart failure landscape
January 12, 2021Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
-
SGLT2 inhibitors in the treatment of HF: the future is bright?
January 12, 2021Cardiologist Perspective on SGLT2 inhibitors
-
SGLT2 inhibition: A snapshot into their evolution
January 12, 2021Endocrinologist Perspective on SGLT2 inhibitors
-
SGLT2 inhibition: Making waves in the heart failure landscape
January 12, 2021Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
-
Residents’ Island: Abidi CVD Prevention Academy
January 12, 2021Multidisciplinary approach to CVD Prevention
-
Save the date: Residents’ Island; Abidi CVD Prevention Academy
January 1, 2021Multidisciplinary approach to CVD Prevention
-
Save the date: SGLT2 inhibition: Making waves in the heart failure landscape
December 31, 2020Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
-
Save the date: Cardiometabolic Grand Round (2)
December 27, 2020A brief talk on DM medication challenges in patients with CVD
-
Impact: EMPA-RESPONSE-AHF
December 7, 2020Empagliflozin effects on clinical outcomes in patients with ADHF (EMPA-RESPONSE-AHF)
-
Cardiometabolic Grand Round (2)
December 7, 2020A brief talk on DM medication challenges in patients with CVD
-
A Polypill For the Prevention of CVD in Intermediate Risk Patients: Results of the International Polycap Study (TIPS-3 Trial)
December 2, 2020A quick review on the findings of TIPS-3 trial from AHA congress 2020
-
The role of Omega 3 and Vitamin D in the Primary Prevention of AF (VITAL-RHYTHM Trial)
December 2, 2020Dietary Supplements and AF
-
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with T2DM and Moderate Renal Impairment Who Are at Cardiovascular Risk (SCORED)
December 2, 2020The Important findings of SCORED trial from AHA 2020 congress in brief
-
Effects of Evolocumab on Complex Coronary Disease Requiring Revascularization
November 30, 2020Evolocumab in the pipeline
-
Sotagliflozin and Cardiovascular Events in T2DM Post Worsening HF (SOLOIST-WHF)
November 30, 2020Sotagliflozin in T2DM and exacerbated HF
-
Ferric Carboxymaltose for iron deficiency at discharge after acute heart failure (AFFIRM-AHF)
November 26, 2020Iron supplementation in acute heart failure
-
Save the Date: Antithrombotic Therapy to Prevent Cardiovascular Events in Type 2 Diabetes
November 4, 2020Comprehensive talk on DAPT vs Low dose Rivaroxaban in patients with T2DM and CVD
-
Treatment goals for LDL cholesterol across categories of total CV risk
November 4, 2020Overview of 2019 ESC/EAS Guidelines for the management of dyslipidemia
-
Finerenone Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease (FIDELIO-DKD Trial)
November 3, 2020Finerenone protecting kidneys
-
Save the date: Cardiometabolic Grand Round
November 1, 2020A brief talk on DM management in patients with CVD
-
-
Monitor eGFR in Patients Treated with Metformin
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Patient factors influencing the selection of glucose-lowering drugs other than SGLT2i and metformin in T2D and CKD
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Glycemic Management for patients with T2DM and CKD
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Monitoring of ACEI/ ARB Treatment in Patients with T2DM and CKD
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Save the date: Comprehensive risk reduction in DM
October 29, 2020Collaborative management of DM: Endocrinologist, Nephrologist and Cardiologist team work
-
How to Implement the Newest Diabetes Therapies in HF Treatment
October 29, 2020New insight from EMPEROR Reduced Trial
-
Save the Date: What we learned from ESC Congress about HTN Management
October 22, 2020A Brief Discussion on HTN Management Pearls of ESC 2020
-
What we learned from ESC Congress about HTN Management
October 22, 2020A Brief Discussion on HTN Management Pearls of ESC 2020
-
Diabetes and Cardiovascular Diseases
September 29, 2020On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors
-
The weight of the world: The global challenge of obesity
September 29, 2020On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors
-
Ground-breaking research from ESC Congress 2020 (12)
September 16, 2020Part Twelve: Trial Review, EVAPORATE
-
Ground-breaking research from ESC Congress 2020 (11)
September 16, 2020Part Eleven: Trial Review, DAPA-CKD
-
Ground-breaking research from ESC Congress 2020 (10)
September 16, 2020Part Ten: Trial Review, DECLARE-TIMI
-
Ground-breaking research from ESC Congress 2020 (3)
September 16, 2020Part Three: Trial Review; THEMIS, PAD
-
Ground-breaking research from ESC Congress 2020 (2)
September 16, 2020Part Two: Trial Review, EMPEROR-REDUCED
-
Save the date: Daily Cardiology Journal Club: 3rd Session – EMPEROR-REDUCED Trial
September 15, 2020Monthly Case-Based Clinical Problem Solving
-
Daily Cardiology Journal Club: 3rd Session – EMPEROR-REDUCED Trial
September 15, 2020Monthly Case-Based Clinical Problem Solving
-
Save the date: Ground-breaking research from ESC Congress 2020
September 10, 2020Brief Review of Main Trials Discussed in ESC Congress 2020
-
Ground-breaking research from ESC Congress 2020
September 10, 2020Brief Review of Main Trials Discussed in ESC Congress 2020
-
-
Impact: Colchicine in patients with acute coronary syndrome
September 1, 2020The findings of COPS trial
-
Impact: Colchicine in patients with chronic coronary syndrome
September 1, 2020The findings of LoDoCo2 trial
-
Impact: cardiovascular and renal outcomes of Empagliflozin in HF
August 31, 2020The findings of EMPEROR-REDUCED trial
-
-
Impact: Intracoronary infusion of bone marrow-derived mononuclear cells in AMI
August 31, 2020The findings of BAMI trial
-
Impact: Time-to-treatment of Colchicine and post-MI cardiovascular outcomes
August 31, 2020The findings of COLCOT trial
-
Save the date: Current Cardiology Practice of Antithrombotics in ASCVD: A Case Based Panel Discussion
August 18, 2020Brief discussion on choice of antithrombotic agents in patients with chronic coronary syndrome and peripheral artery disease
-
Current Cardiology Practice of Antithrombotics in ASCVD: A Case Based Panel Discussion
August 18, 2020Brief discussion on choice of antithrombotic agents in patients with chronic coronary syndrome and peripheral artery disease
-
Case Discussion (29)
August 12, 2020Pharmacotherapy approach to ACE/ARB induced AKI in HFrEF patients
-
-
Save the date: Cardiometabolic Care Network
July 16, 2020Interprofessional Collaboration Practice in Risk Management of ASCVD
-
Cardiometabolic Care Network
July 16, 2020Interprofessional Collaboration Practice in Risk Management of ASCVD
-
-
Save the date: Optimizing Heart Failure Care Throughout the Patient Journey
June 30, 2020A Case Based Panel Comprehensive Discussion on HF Pharmacotherapy
-
Optimizing Heart Failure Care Throughout the Patient Journey
June 25, 2020A Case Based Panel Comprehensive Discussion on HF Pharmacotherapy
-
-
CardioPoint (8): When to consider drug treatment in hypertension?
May 24, 2020A Brief Description on Practical Points in Cardiometabolic Field
-
-
COVID and Cardiometabolic Challenges
April 10, 2020Multidisciplinary approach to COVID-19 Cardiometabolic Complications
-
Save the date: COVID and Cardiometabolic Challenges
April 3, 2020Multidisciplinary approach to COVID-19 Cardiometabolic Complications
-
Cardiovascular medication interactions with antiviral agents used for COVID-19
March 3, 2020Quick review of CV medications interactions with medications used for COVID-19
-
Cardiovascular medication interactions with antiviral agents used for COVID-19: Second Update
March 3, 2020Quick review of CV medications interactions with medications used for COVID-19
-
Predicting the Risk of Post-stroke Atrial Cardiopathy
February 27, 2020An interim analysis from ACARDIA trial
-
Dapagliflozin in concurrent Atrial Fibrillation and T2DM
February 12, 2020Insights from DECLARE-TIMI 58 Trial
-
Intensive LDL lowering beyond current recommendations for MACE prevention
February 12, 2020A meta-analysis of RCTs
-
-
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in T2DM
January 18, 2020The renal and cardiovascular protective effects of SGLT2 inhibitors
-
Intensive Blood Pressure lowering and the Concerns about Falling
January 18, 2020The findings of SPRINT trial
-
-
Guideline Made Easy
December 7, 2019Practical Guide for Treatment of High Blood Pressure (Part Three)
-
Guideline Made Easy
December 7, 2019Practical Guide for Treatment of High Blood Pressure (Part Two)
-
Guideline Made Easy
December 7, 2019Practical Guide for Treatment of High Blood Pressure (Part One)
-
-
Inclisiran for patients with ASCVD and elevated LDL
December 2, 2019The findings of ORION-10 trial in ASCVD patients
-
Dapagliflozin in non-DM Patients with HF and Reduced EF
December 2, 2019The findings of DAPA-HF trial in non-diabetics
-
Inclisiran in Heterozygous Familial Hypercholesterolemia (HeFH) and Elevated LDL
November 29, 2019The findings of ORION-9 trial about Inclisiran in HeFH
-
The Efficacy and Safety of Low-Dose Colchicine after MI
November 29, 2019The findings of COLCOT trial about colchicine post-MI
-
CardioPoint (6): Treatment Target & Goal for LDL-Cholesterol
November 29, 2019A Brief Description on Practical Points in Cardiometabolic Field
-
Optimal Medical Therapy vs. Revascularization in Chronic Coronary Syndrome
November 29, 2019The findings of ISCHEMIA trial
-
Anti-ischemic Medications
November 19, 2019Pass the torch: Educational sessions for Interventional Cardiologists, Review of ESC 2019 CCS Guideline
-
Triglyceride Lowering and Cardiovascular Risk Reduction
November 4, 2019A Systematic Review and Meta-Analysis of RCTs on TG lowering drugs
-
Guideline Made Easy
November 3, 2019Practical Guide for treatment of high blood cholesterol Part Three
-
-
Daily Cardiology Cath-Conference: Case no. 2
October 23, 2019The second case of Daily Cardiology Cath-Conference
-
Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease
October 15, 2019The findings of EXCEL Trial
-
Cardiology Close-Up (7)
October 7, 2019Pharmacologic Therapy for LDL Cholesterol Treatment Goal and Pharmacologic Therapy for LDL Cholesterol
-
Guideline Made Easy
October 3, 2019Practical Guide for treatment of high blood cholesterol Part Two
-
CardioPoint (4): Fixed-Dose Combination Pills in the Management of Hypertension
September 20, 2019A Brief Description on Practical Points in Cardiometabolic Field
-
OAC Monotherapy in Patients with Stable CAD and Non-valvular AF
August 20, 2019OACs in Stable CAD and AF
-
Optimal Timing of P2Y12 Inhibitor Loading in Patients Undergoing PCI
August 3, 2019P2Y12 loading dose timing in PCI
-
Ezetimibe for the prevention of heart disease and death
June 14, 2019The role of Ezetimibe in reducing CVD adverse outcomes
-
-
CardioPoint (1):Statins-Who is eligible?-Which dose?
May 19, 2019A Brief Description on Practical Points in Cardiometabolic Field
-
-
